nodes	percent_of_prediction	percent_of_DWPC	metapath
Frovatriptan—HTR1D—Serotonin receptors—HTR2A—narcolepsy	0.0363	0.0381	CbGpPWpGaD
Frovatriptan—HTR1B—Serotonin receptors—HTR2A—narcolepsy	0.0356	0.0373	CbGpPWpGaD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HRH3—narcolepsy	0.0273	0.0286	CbGpPWpGaD
Frovatriptan—HTR1A—Serotonin receptors—HTR2A—narcolepsy	0.0271	0.0284	CbGpPWpGaD
Frovatriptan—HTR1B—Amine ligand-binding receptors—HRH3—narcolepsy	0.0267	0.028	CbGpPWpGaD
Frovatriptan—HTR1A—Amine ligand-binding receptors—HRH3—narcolepsy	0.0203	0.0214	CbGpPWpGaD
Frovatriptan—HTR1D—Monoamine GPCRs—HTR2A—narcolepsy	0.0162	0.017	CbGpPWpGaD
Frovatriptan—HTR1B—Monoamine GPCRs—HTR2A—narcolepsy	0.0158	0.0166	CbGpPWpGaD
Frovatriptan—HTR1D—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0136	0.0143	CbGpPWpGaD
Frovatriptan—HTR1B—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0133	0.014	CbGpPWpGaD
Frovatriptan—HTR1A—Monoamine GPCRs—HTR2A—narcolepsy	0.0121	0.0127	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0115	0.012	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0115	0.012	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.0112	0.0118	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.0112	0.0118	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0111	0.0116	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.0108	0.0114	CbGpPWpGaD
Frovatriptan—HTR1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0101	0.0106	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00983	0.0103	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00983	0.0103	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00962	0.0101	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00962	0.0101	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00949	0.00996	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00929	0.00976	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—PENK—narcolepsy	0.00905	0.0095	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—PENK—narcolepsy	0.00886	0.0093	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00855	0.00898	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00855	0.00898	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00826	0.00868	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00807	0.00847	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.0079	0.0083	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HCRTR2—narcolepsy	0.00748	0.00786	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HCRTR1—narcolepsy	0.00748	0.00786	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00733	0.0077	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00733	0.0077	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HCRTR1—narcolepsy	0.00733	0.00769	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HCRTR2—narcolepsy	0.00733	0.00769	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—P2RY11—narcolepsy	0.00723	0.00759	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00719	0.00755	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00708	0.00743	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—P2RY11—narcolepsy	0.00708	0.00743	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00704	0.00739	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—PENK—narcolepsy	0.00675	0.00708	CbGpPWpGaD
Frovatriptan—HTR1D—G alpha (i) signalling events—HRH3—narcolepsy	0.00674	0.00708	CbGpPWpGaD
Frovatriptan—HTR1B—G alpha (i) signalling events—HRH3—narcolepsy	0.0066	0.00693	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00626	0.00657	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HCRT—narcolepsy	0.00614	0.00645	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00613	0.00643	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00612	0.00642	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00602	0.00632	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HCRT—narcolepsy	0.00602	0.00632	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00599	0.00629	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00579	0.00607	CbGpPWpGaD
Frovatriptan—HTR1B—brainstem—narcolepsy	0.00572	0.12	CbGeAlD
Frovatriptan—HTR1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00558	0.00586	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00558	0.00586	CbGpPWpGaD
Frovatriptan—HTR1D—brainstem—narcolepsy	0.00553	0.116	CbGeAlD
Frovatriptan—HTR1B—forebrain—narcolepsy	0.00552	0.116	CbGeAlD
Frovatriptan—HTR1D—GPCR ligand binding—PENK—narcolepsy	0.00548	0.00575	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—P2RY11—narcolepsy	0.00539	0.00566	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00536	0.00563	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—PENK—narcolepsy	0.00536	0.00563	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00536	0.00563	CbGpPWpGaD
Frovatriptan—HTR1D—forebrain—narcolepsy	0.00534	0.112	CbGeAlD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00525	0.00551	CbGpPWpGaD
Frovatriptan—HTR1A—G alpha (i) signalling events—HRH3—narcolepsy	0.00503	0.00528	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00467	0.0049	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—TRH—narcolepsy	0.00466	0.00489	CbGpPWpGaD
Frovatriptan—HTR1A—brainstem—narcolepsy	0.00461	0.0968	CbGeAlD
Frovatriptan—HTR1A—GPCR ligand binding—HCRT—narcolepsy	0.00458	0.00481	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00456	0.00479	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—TRH—narcolepsy	0.00456	0.00479	CbGpPWpGaD
Frovatriptan—HTR1A—forebrain—narcolepsy	0.00445	0.0934	CbGeAlD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00444	0.00467	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00444	0.00467	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00435	0.00457	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00435	0.00457	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HCRTR1—narcolepsy	0.00423	0.00444	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HCRTR2—narcolepsy	0.00423	0.00444	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00414	0.00435	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00414	0.00435	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—PENK—narcolepsy	0.00409	0.00429	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—P2RY11—narcolepsy	0.00408	0.00429	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HRH3—narcolepsy	0.00408	0.00429	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.004	0.0042	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—P2RY11—narcolepsy	0.004	0.0042	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HRH3—narcolepsy	0.004	0.0042	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HCRTR1—narcolepsy	0.00384	0.00403	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HCRTR2—narcolepsy	0.00384	0.00403	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HCRTR2—narcolepsy	0.00376	0.00395	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HCRTR1—narcolepsy	0.00376	0.00395	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—P2RY11—narcolepsy	0.00371	0.00389	CbGpPWpGaD
Frovatriptan—HTR1B—midbrain—narcolepsy	0.00364	0.0765	CbGeAlD
Frovatriptan—HTR1B—Signaling by GPCR—P2RY11—narcolepsy	0.00363	0.00381	CbGpPWpGaD
Frovatriptan—HTR1D—midbrain—narcolepsy	0.00353	0.074	CbGeAlD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.00348	0.00365	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TRH—narcolepsy	0.00347	0.00365	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HCRT—narcolepsy	0.00347	0.00365	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HCRT—narcolepsy	0.0034	0.00357	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—TAC1—narcolepsy	0.00338	0.00355	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—NPS—narcolepsy	0.00338	0.00355	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00331	0.00348	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00331	0.00348	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—NPS—narcolepsy	0.00331	0.00348	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—TAC1—narcolepsy	0.00331	0.00348	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00315	0.00331	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00315	0.00331	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HCRT—narcolepsy	0.00315	0.00331	CbGpPWpGaD
Frovatriptan—HTR1D—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00312	0.00328	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—PENK—narcolepsy	0.00309	0.00325	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HCRT—narcolepsy	0.00309	0.00324	CbGpPWpGaD
Frovatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00305	0.00321	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00305	0.0032	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HRH3—narcolepsy	0.00305	0.0032	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—PENK—narcolepsy	0.00303	0.00318	CbGpPWpGaD
Frovatriptan—HTR1A—midbrain—narcolepsy	0.00294	0.0617	CbGeAlD
Frovatriptan—HTR1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00286	0.00301	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00286	0.00301	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—PENK—narcolepsy	0.00281	0.00295	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—P2RY11—narcolepsy	0.00277	0.0029	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—PENK—narcolepsy	0.00275	0.00289	CbGpPWpGaD
Frovatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00267	0.00281	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TRH—narcolepsy	0.00263	0.00276	CbGpPWpGaD
Frovatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00262	0.00275	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HCRT—narcolepsy	0.00259	0.00272	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TRH—narcolepsy	0.00258	0.00271	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—TAC1—narcolepsy	0.00252	0.00265	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—NPS—narcolepsy	0.00252	0.00265	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TRH—narcolepsy	0.00239	0.00251	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HCRT—narcolepsy	0.00235	0.00247	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TRH—narcolepsy	0.00234	0.00246	CbGpPWpGaD
Frovatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00233	0.00244	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—PENK—narcolepsy	0.00231	0.00242	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HRH3—narcolepsy	0.00231	0.00242	CbGpPWpGaD
Frovatriptan—HTR1B—brain—narcolepsy	0.00229	0.048	CbGeAlD
Frovatriptan—HTR1D—Signaling Pathways—HCRTR2—narcolepsy	0.00227	0.00238	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HCRTR1—narcolepsy	0.00227	0.00238	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HRH3—narcolepsy	0.00226	0.00237	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.00224	0.00235	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HCRTR2—narcolepsy	0.00222	0.00233	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HCRTR1—narcolepsy	0.00222	0.00233	CbGpPWpGaD
Frovatriptan—HTR1D—brain—narcolepsy	0.00222	0.0465	CbGeAlD
Frovatriptan—HTR1D—Signaling Pathways—P2RY11—narcolepsy	0.00219	0.0023	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—P2RY11—narcolepsy	0.00215	0.00225	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—PENK—narcolepsy	0.0021	0.0022	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HRH3—narcolepsy	0.0021	0.0022	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HRH3—narcolepsy	0.00205	0.00215	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR ligand binding—HTR2A—narcolepsy	0.00204	0.00214	CbGpPWpGaD
Frovatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00199	0.00209	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR ligand binding—HTR2A—narcolepsy	0.00199	0.00209	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TRH—narcolepsy	0.00196	0.00206	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—NPS—narcolepsy	0.00191	0.00201	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—TAC1—narcolepsy	0.00191	0.00201	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—NPS—narcolepsy	0.00187	0.00197	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—TAC1—narcolepsy	0.00187	0.00197	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HCRT—narcolepsy	0.00186	0.00196	CbGpPWpGaD
Frovatriptan—HTR1A—brain—narcolepsy	0.00185	0.0388	CbGeAlD
Frovatriptan—HTR1B—Signaling Pathways—HCRT—narcolepsy	0.00182	0.00192	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TRH—narcolepsy	0.00178	0.00187	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—NPS—narcolepsy	0.00174	0.00182	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—TAC1—narcolepsy	0.00174	0.00182	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.00172	0.00181	CbGpPWpGaD
Frovatriptan—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.00172	0.00181	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HRH3—narcolepsy	0.00172	0.00181	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—NPS—narcolepsy	0.0017	0.00179	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—TAC1—narcolepsy	0.0017	0.00179	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HCRTR1—narcolepsy	0.00169	0.00178	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HCRTR2—narcolepsy	0.00169	0.00178	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—PENK—narcolepsy	0.00166	0.00174	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—P2RY11—narcolepsy	0.00163	0.00172	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—PENK—narcolepsy	0.00163	0.00171	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HRH3—narcolepsy	0.00156	0.00164	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.00152	0.0016	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR ligand binding—HTR2A—narcolepsy	0.00152	0.00159	CbGpPWpGaD
Frovatriptan—HTR1A—SIDS Susceptibility Pathways—TNF—narcolepsy	0.0015	0.00157	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—TAC1—narcolepsy	0.00143	0.0015	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—NPS—narcolepsy	0.00143	0.0015	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TRH—narcolepsy	0.00141	0.00148	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HCRT—narcolepsy	0.00139	0.00146	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TRH—narcolepsy	0.00138	0.00145	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—TAC1—narcolepsy	0.0013	0.00136	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—NPS—narcolepsy	0.0013	0.00136	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—PENK—narcolepsy	0.00124	0.0013	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HRH3—narcolepsy	0.00124	0.0013	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HRH3—narcolepsy	0.00121	0.00127	CbGpPWpGaD
Frovatriptan—HTR1D—GPCR downstream signaling—HTR2A—narcolepsy	0.00115	0.00121	CbGpPWpGaD
Frovatriptan—HTR1B—GPCR downstream signaling—HTR2A—narcolepsy	0.00113	0.00118	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TRH—narcolepsy	0.00105	0.00111	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling by GPCR—HTR2A—narcolepsy	0.00104	0.0011	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—NPS—narcolepsy	0.00103	0.00108	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—TAC1—narcolepsy	0.00103	0.00108	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling by GPCR—HTR2A—narcolepsy	0.00102	0.00107	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—TAC1—narcolepsy	0.001	0.00105	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—NPS—narcolepsy	0.001	0.00105	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CHKB—narcolepsy	0.000997	0.00105	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HRH3—narcolepsy	0.000923	0.00097	CbGpPWpGaD
Frovatriptan—HTR1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000858	0.000901	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling by GPCR—HTR2A—narcolepsy	0.000779	0.000818	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—NPS—narcolepsy	0.000765	0.000803	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—TAC1—narcolepsy	0.000765	0.000803	CbGpPWpGaD
Frovatriptan—CYP1A2—Metabolism—CPT1B—narcolepsy	0.000678	0.000712	CbGpPWpGaD
Frovatriptan—HTR1D—Signaling Pathways—HTR2A—narcolepsy	0.000617	0.000648	CbGpPWpGaD
Frovatriptan—HTR1B—Signaling Pathways—HTR2A—narcolepsy	0.000604	0.000634	CbGpPWpGaD
Frovatriptan—HTR1A—Signaling Pathways—HTR2A—narcolepsy	0.00046	0.000483	CbGpPWpGaD
